Eczacibasi Ilac Sanayi ve T.A.S. operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Eczacibasi Ilac Sanayi ve T.A.S. with three other
pharmaceutical manufacturers in Europe:
of the United Kingdom
sales of £171.67 million [US$214.32 million]
of which 100%
was Antibodies & Related Products),
Laboratorios Farmaceuticos Rovi S.A.
(265.17 million Euro [US$286.67 million]
of which 88%
was Marketing), and
Moberg Pharma AB (publ)
based in Sweden
(334.30 million Swedish Kronor [US$38.01 million]
Eczacibasi Ilac Sanayi ve T.A.S. reported sales of 1.41 billion Turkish Liras (US$388.84 million)
December of 2016.
increase of 20.7%
versus 2015, when the company's sales were 1.17 billion Turkish Liras.
Sales of Health saw an increase
that was more than double the company's growth rate: sales were up
61.0% in 2016, from
237.09 million Turkish Liras to 381.79 million Turkish Liras.